Disc Medicine, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Disc Medicine, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q3 2024.
Disc Medicine, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $4.33M, a 241% increase year-over-year.
Disc Medicine, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $14.4M, a 213% increase year-over-year.
Disc Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.53M, a 165% increase from 2022.
Disc Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.09M, a 312% increase from 2021.
Disc Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $507K, a 48.4% decline from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$14.4M	$4.33M	+$3.06M	+241%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$11.3M	$4.09M	+$2.78M	+213%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$8.56M	$4.06M	+$3.03M	+296%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$5.53M	$1.93M	+$934K	+94.1%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-21
Q3 2023	$4.6M	$1.27M	+$888K	+232%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-12
Q2 2023	$3.71M	$1.31M	+$927K	+243%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023	$2.78M	$1.02M	+$692K	+208%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	$2.09M	$993K	+$6.6M		Oct 1, 2022	Dec 31, 2022	10-K	2024-03-21
Q3 2022	-$4.51M	$382K	-$1.28M	-77%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	-$3.23M	$382K	-$2.48M	-86.7%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-11
Q1 2022	-$754K	$332K	-$1.26M	-79.2%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	$507K	-$5.61M	-$6.2M	-1050%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-31
Q3 2021	$6.7M	$1.66M	+$1.5M	+930%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-10
Q2 2021	$5.21M	$2.86M	+$2.72M	+1974%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	$2.48M	$1.59M	+$1.5M	+1595%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-06
Q4 2020	$983K	$590K			Oct 1, 2020	Dec 31, 2020	10-K	2022-03-10
Q3 2020		$161K			Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-15
Q2 2020		$138K			Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020		$94K			Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.